T. Rowe Price Investment Management’s Cardinal Health CAH Stock Holding History

T. Rowe Price Investment Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.54M	Sell	10,692 -685	-6%	-$142K	﹤0.01%	678
2026 Q1	$2.4M	Buy	11,377 +2,760	+32%	+$594K	﹤0.01%	590
2025 Q4	$1.77M	Sell	8,617 -11,589	-57%	-$2.18M	﹤0.01%	629
2025 Q3	$3.17M	Sell	20,206 -751,584	-97%	-$116M	﹤0.01%	591
2025 Q2	$130M	Buy	771,790 +10,009	+1%	+$1.49M	0.08%	231
2025 Q1	$105M	Buy	+761,781	New	+$97.1M	0.07%	268

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Investment Management's CAH Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its Cardinal Health (CAH) stake by 6% in Q2 2026, selling an estimated $142K and leaving 10,692 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #678.

T. Rowe Price Investment Management first reported a position in CAH in Q1 2025 and has held it in 6 quarters since. The position peaked at $130M in Q2 2025. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

T. Rowe Price Investment Management held 10,692 shares of Cardinal Health worth $2.54M as of Q2 2026.
T. Rowe Price Investment Management sold 685 Cardinal Health shares in Q2 2026, an estimated $142K.
Cardinal Health made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #678 holding.
T. Rowe Price Investment Management first reported a position in Cardinal Health in Q1 2025 and has held it in 6 quarters since.
T. Rowe Price Investment Management's Cardinal Health position peaked at $130M in Q2 2025.
1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.